Access cutting-edge early alzheimer's disease treatment through this clinical trial at a research site in Scottsdale. Study-provided care at no cost to qualified participants.
Access early alzheimer's disease specialists in Scottsdale at no cost
This study follows strict safety protocols and ethical guidelines
All study-related early alzheimer's disease treatment provided free
The goal of this clinical trial is to learn if buntanetap/Posiphen works to treat early Alzheimer's disease in adults aged 55-85. It will also learn about the safety of buntanetap/Posiphen. The main questions it aims to answer are: * Does buntanetap/Posiphen improve cognition as measured by ADAS-Cog13? * Does buntanetap/Posiphen improve function as measured by ADCS-iADL? * What medical issues do participants have, if any, when taking buntanetap/Posiphen? Researchers will compare buntanetap/Pos
Sponsor: Annovis Bio Inc.
Check if you qualify for this early alzheimer's disease clinical trial in Scottsdale, AZ
If you're searching for early alzheimer's disease treatment options in Scottsdale, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Scottsdale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced early alzheimer's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.